Page 47 - Read Online
P. 47

Prognostic factors in betel and tobacco related oral cancer.  Oral Oncol   in oral carcinoma in a population of Brazilian patients.  J Appl Oral Sci
              2002;38:491-9.                                      2008;16:340-4.
           4.   Frances chi S, Levi F, La Vecchia C, Conti E, Dal Maso L, Barzan L, Talamini   29.  El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in
              R. Comparison of the effect of smoking and alcohol drinking between oral   squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in
              and pharyngeal cancer. Int J Cancer 1999;83:1-4.    young patients: a distinct clinicopathologic and molecular disease entity.
           5.   La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology   AM J Surg Pathol 2003;27:1463-70.
              and prevention of oral cancer. Oral Oncol 1997;33:302-12.  30.  El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal
           6.   Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak   nonkeratinizing squamous cell carcinoma: characterization of a distint
              ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for   phenotype. Oral Surg Oral Med Oral Pahol Oral Radiol Endod 2006;101:339-45.
              causal association between human papillomavirus and a subset of head and   31.  Chen SF, Yu FS, Chang YC, Fu E, Nieh S, Lin YS. Role of human papillomavirus
              neck cancers. J Natl Cancer Inst 2000;92:709-20.    infection in carcinogenesis of oral squamous cell carcinoma with evidences
           7.   D'Souza  G1,  Kreimer  AR, Viscidi  R,  Pawlita  M,  Fakhry  C,  Koch  WM,   of prognostic association. J Oral Pathol Med 2012;41:9-15.
              Westra WH, Gillison ML. Case-control study of human papillomavirus and   32.  Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladström
              oropharyngeal cancer. N Engl J Med 2007;356:1944-56.  A,  Andersson G. Recurrence in patients with oral and oropharyngeal
           8.   Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO,   squamous cell carcinoma: human papillomavirus and other risk factors.
              Joneberg  J,  Creson  N,  Lindholm  J, Ye W,  Dalianis T,  Munck-Wikland  E.   Acta Otolaryngol 2007;127:980-7.
              Human papillomavirus as a risk factor for the increase in incidence of   33.  Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral
              tonsillar cancer. Int J Cancer 2006;110:2620-3.     squamous cell carcinoma: a meta-analysis. Oral Surg Oral Med Oral Pathol
           9.   Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human   Oral Radiol Endod 2001;91:622-35.
              papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of   34.  Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J,  Gill S,
              relapse, and survival. Int J Cancer 2000:89:300-4.  Frustino J, Wilding G, Loree T, Popat S, Sullivan M. Human papillomavirus
           10.  Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus   types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a
              in head and neck cancer: an association of HPV 16 with squamous cell   meta-analysis, 1985-2010. Oral Oncol 2011;47:1048-54.
              carcinoma of Waldeyer’s tonsillar ring. Cancer 1997;79:595-604.  35.  Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and
           11.  Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing   neck in relation to  human papillomavirus infection: review and meta-
              trends in the US population ages 20-44 years. Cancer 2005;103:1843-9.  analysis. Int J Cancer 2007;121:1813-20.
           12.  Canto MT, Devesa SS. Oral cavity and pharynx cancer incidences rates in   36.  Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A,
              the United Sates, 1975-1998. Oral Oncol 2002;38:610-7.  Gillison ML. Improved survival of patients with human papillomavirus-
           13.  Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar   positive head and neck squamous cell carcinoma in a prospective clinical
              squamous cell carcinoma in the United States.  Cancer Causes Control   trial. J Natl Cancer Inst 2008;100:261-9.
              2000;11:489-95.                                  37.  Rischin D, Young RJ, Fisher R, Fox SB, Le  QT, Peters LJ, Solomon B,
           14.  Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus   Choi  J,  O'Sullivan  B,  Kenny  LM,  McArthur  GA.  Prognostic  significance
              types in head and neck squamous cell carcinoma worldwide: a systematic   of p16INK4A and human papillomavirus in patients with oropharyngeal
              review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75.  cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010;28:4142-8.
           15.  Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological   38.  Ang  KK,  Harris  J, Wheeler  R, Weber  R,  Rosenthal  DI,  Nguyen-Tân  PF,
              and inmunohistochemical evidence suggesting human papillomavirus   Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC,
              (HPV)  involvement  in  oral  squamous  cell  carcinogenesis.  Int  J  Oral  Surg   Redmond KP, Gillison ML. Human papillomavirus and survival of patients
              1983;12:418-24.                                     with oropharyngeal cancer. N Engl J Med 2010;363:24-35.
           16.  Franceschi  S,  Muñoz  N,  Bosch  XF,  Snijders PJ, Walboomers  JM.  Human   39.  Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen
              papillomavirus and cancers of the upper aerodigestive tract: a review of   LJ,  Evensen  JF7,  Eriksen  JG8,  Overgaard  J8;  Danish  Head  and  Neck
              epidemiological  and  experimental  evidence.  Cancer  Epidemiol  Biomarkers   Cancer  Group  (DAHANCA).  Impact  of  HPV-associated  p16-expression
              Prev 1996;5:567-75.                                 on radiotherapy outcome in advanced oropharynx and non-oropharynx
           17.  Lönging T, Ikenberg H, Becker J,  Gissmann L,  Hoepfer I, zur Hausen H.   cancer. Radiother Oncol 2014;113:310-6.
              Analysis of oral papillomas, leukoplakias, and invasive carcinomas for   40.  De Villiers EM. Papillomavirus and HPV typing. Clin Dermatol 1997;15:199-206.
              human papillomavirus type related DNA. J Invest Dermatol 1985;84:417-20.  41.  Van Regenmortel MHV FC, Fauquet CM, Bishop DHL, Carsten EB, Estes
           18.  Tran N, Rose BR, O’Brien CJ. Role of human papillomavirus in the etiology   MK, Lemon SM, Maniloff J, Mayo MA, McGeoch DJ, Pringle CR, Wickner RB.
              of head and neck cancer. Head Neck 2007;29:64-70.   Virus taxonomy: classification and nomenclature of viruses. Seventh report
           19.  Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head   of the International Committee on Taxonomy of Viruses. New York, San
              and neck cancer: a focus on human papillomavirus. J Dent Res 2007;86:104-14.  Diego: Academic Press; 2000.
           20.  Gillson ML. Human papillomavirus-associated head and neck cancer   42.  Howley PM. Role of the human papillomaviruses in human cancer. Cancer
              is a distinct epidemiologic, clinical and molecular entity.  Semin Oncol   Res 1991;51:S5019-22.
              2004;31:744-54.                                  43.  Cobb MW. Human papillomavirus infection.  J Am Acad  Dermatol
           21.  Dahstrand H, Dahlgren L, Lindquist D, MunckWikland E, Dalianis  T.   1990;22:547-66.
              Presence of human papillomavirus in tonsillar cancer is a favourable   44.  Campsini G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, Di
              prognostic factor for clinical outcome. Anticancer Res 2004;24:1829-35.  Liberto C, Scully C, Lo Muzio L. Human papillomavirus: its identikit and
           22.  Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck.   controversial role in oral oncogenesis, premalignant and malignant lesions
              BMJ 2002;325:822-7.                                 (Review). Int J Oncol 2007;30:813-23.
           23.  Gillison ML, Lowy DR. A causal role for human papillomavirus in head and   45.  Cason J, Kaye J, Pakarian F, Raju KS, Best JM. HPV-16 transmission. Lancet
              neck cancer. Lancet 2004;365:1488-9.                1995;345:197-8.
           24.  Miller CS, White DK. Human Papillomavirus expression in oral mucosa,   46.  Mindel  A, Tideman  R.  HPV  transmission  -  still  feeling  the  way.  Lancet
              premalignant conditions, and squamous cell carcinoma: a retrospective   1999;354:2097-8.
              review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod   47.  Hiller T, Iftner T. The human papillomavirus. In: Prendiville W, Davies P, editors.
              1996;82:57-68.                                      Human papillomavirus and cervical cancer. The Health Professional’s HPV
           25.  Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio   Handbook. London and New York: Taylor & Francis; 2004. p. 11-26.
              L, Campisi G. HPV in oral squamous cell carcinoma  vs.  head and neck   48.  Antonsson A, Forslund O, Ekburg H, Sterner G, Hanson BG. The ubiquity
              squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol   and impressive genomic diversity of human skin papillomavirus suggest a
              2008;19:1681-90.                                    commensalic nature of these viruses. J Virol 2000;74:11636-41.
           26.  Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Fréneaux P,   49.  Chang F. Role of papillomaviruses. J Clin Pathol 1990;43:269-76.
              Point D, Girod A, Rodriguez J, Sastre-Garau X. Two types of squamous   50.  World Health Organization; International Agency for Research on Cancer
              cell  carcinoma  of  the  palatine  tonsil  characterized  by  distinct  etiology,   (IARC).  Human  papillomavirus.  IARC  Monogr  Eval  Carcinog  Rsk  Hum
              molecular features and outcome. Cancer Lett 2008;260:72-8.  2007;90:47-79,113-7.
           27.  Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos I,   51.  De  Villiers EM, Gunst K. Characterization of seven novel human
              Stein H. Detection of human papillomavirus type 16 DNA in carcinomas of   papillomavirus types isolated from cutaneous tissue, but also present in
              the palatine tonsil. J Clin Pathol 1990;43:918-21.  mucosal lesions. J Gen Virol 2009;90:1994-2004.
           28.  Soares RC, Oliveira MC, de Souza LB, Costa Ade L, Pinto LP. Detection   52.  De  Villiers EM,  Faquet C, Broker  TR,  Bernard  HU,  Zur Hausen  H.
              of HPV DNA and inmunohistochemical expression of cell cycle proteins   Classification of papillomaviruses. Virology 2004;324:17-27.
           Plast Aesthet Res || Volume 3 || May 25, 2016                                                      139
   42   43   44   45   46   47   48   49   50   51   52